Company intelligence / Profile preview

FuXion Biotech

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

FuXion Biotech commercializes a broad portfolio of patented nutraceutical beverage mixes designed to promote general wellness, immune function, sports performance/recovery, and weight management. Their products are based on proprietary blends of proteins and plant extracts with claimed benefits supported by years of research investment. No clinical trial data in the pharmaceutical sense; efficacy claims are based on nutritional science.

Therapeutic areas: OtherMetabolic DisordersImmunology
Modalities: Nutraceutical food products (functional beverages)Protein blends (e.g., colostrum-based protein)Bioactive peptides/proteins from natural sourcesPlant and animal-derived extracts for health support
Industry: Food & Nutrition

Beyond the preview

Go deeper on FuXion Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FuXion Biotech.

Explore the full profile